Recent research suggests that CCAT1 promotes colon cancer cell growth by increasing expression of the oncoprotein c-MYC and the oncogenic mRNA tumor suppressor candidate 3 (TUSC3), the target of miR-181b-5p in CRC cells, thus increasing glucose metabolism to fuel colon cancer cell growth. The gene discussed is MYC; the disease is malignant colon neoplasm.